liarozole has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdolell, M; Blackstein, M; Clemons, M; Crump, M; De Coster, R; Goel, R; Goss, PE; Kaizer, L; Marques, R; Nabholtz, JM; Oza, A; Qi, S; Sterns, EE; Strasser, K | 1 |
| Goss, PE; Hu, H; Qi, S; Strasser-Weippl, K | 1 |
1 trial(s) available for liarozole and tamoxifen
| Article | Year |
|---|---|
Liarozole fumarate (R85246): in the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estradiol; Female; Humans; Imidazoles; Mammary Neoplasms, Experimental; Middle Aged; Neoplasm Metastasis; Postmenopause; Quality of Life; Rats; Receptors, Estrogen; Tamoxifen; Treatment Outcome | 2000 |
1 other study(ies) available for liarozole and tamoxifen
| Article | Year |
|---|---|
Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Female; Imidazoles; Methylnitrosourea; Ovariectomy; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 2007 |